#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15624	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2152	722.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1537	1537	C	936	C	862	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15624	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2152	722.5	0	HET	.	.	.	C519T	.	519	519	C	872	872	C	890	C,T	647,173	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28268	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3627	777.7	0	.	n	.	0	G540A	SNP	540	540	G	892	892	A	907	A,G	632,195	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28268	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3627	777.7	0	.	n	.	0	T695C	SNP	695	695	T	1047	1047	C	823	C	758	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28268	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3627	777.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1689	1689	A	936	A	858	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28268	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3627	777.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2323	2323	C	961	C,T	882,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28268	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3627	777.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2949	2949	T	891	T	833	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28268	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3627	777.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2397	2397	A	918	A	851	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2106	folP	852	852	100.0	folP.l6.c30.ctg.1	1741	120.7	1	SNP	p	R228S	1	.	.	682	684	AGC	1101	1103	AGC	233;233;232	A;G;C	216;214;214	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5542	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3372	163.7	1	SNP	p	S91F	0	.	.	271	273	TCC	582	584	TCC	174;175;176	T;C,T;C	164;164,1;166	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5542	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3372	163.7	1	SNP	p	D95N	0	.	.	283	285	GAC	594	596	GAC	171;173;174	G;A;C	160;160;159	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5542	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3372	163.7	1	SNP	p	D95G	0	.	.	283	285	GAC	594	596	GAC	171;173;174	G;A;C	160;160;159	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1598	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1418	112.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	486	488	ACC	178;178;174	A;C;C	166;169;166	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1598	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1418	112.6	0	.	p	.	0	R44H	NONSYN	130	132	CGC	501	503	CAC	164;165;166	C;A;C	155;156;155	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1598	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1418	112.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	684	686	CAC	191;191;190	C,A;A;C	178,1;176;177	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1598	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1418	112.6	1	SNP	p	G45D	0	.	.	133	135	GGC	504	506	GGC	170;173;174	G;G;C	163;165;167	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	868	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	944	91.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5492	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2939	186.2	1	SNP	p	D86N	0	.	.	256	258	GAC	588	590	GAC	224;227;227	G;A;C	211;213;214	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5492	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2939	186.2	1	SNP	p	S87W	0	.	.	259	261	AGT	591	593	AGT	230;230;230	A;G;T,A	218;217;217,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5492	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2939	186.2	1	SNP	p	S87R	0	.	.	259	261	AGT	591	593	AGT	230;230;230	A;G;T,A	218;217;217,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5492	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2939	186.2	1	SNP	p	S87I	0	.	.	259	261	AGT	591	593	AGT	230;230;230	A;G;T,A	218;217;217,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5492	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2939	186.2	1	SNP	p	S88P	0	.	.	262	264	TCC	594	596	TCC	229;229;229	T,A;C;C	217,1;218;217	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4448	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2616	169.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1556	1558	GGC	205;205;203	G;G;C	187;187;182	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4128	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2400	171.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1270	1272	GCA	215;218;218	G;C;A	197;200;200	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4128	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2400	171.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1273	1275	ATC	222;225;220	A;T;C,A	203;206;201,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4128	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2400	171.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1285	1287	GTG	225;226;226	G;T;G	208;208;210	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4128	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2400	171.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1285	1287	GTG	225;226;226	G;T;G	208;208;210	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4128	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2400	171.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1789	1791	ACC	218;215;217	A;C;C	198;195;198	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4128	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2400	171.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1843	1845	GCG	213;214;218	G;C;G	181;170;176	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4128	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2400	171.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1843	1845	GCG	213;214;218	G;C;G	181;170;176	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4128	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2400	171.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1966	1968	GGC	162;158;155	G;G;C	150;147;145	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4128	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2400	171.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1975	1977	GGC	156;157;157	G;G;C	145;146;146	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4128	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2400	171.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1993	1995	CCG	141;141;139	C,G;C,G;G	110,6;111,1;110	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5878	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3297	177.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2258	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1813	124.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	548	548	C	187	C	166	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2874	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1436	198.7	0	.	p	.	0	E48G	NONSYN	142	144	GAA	383	385	GGA	243;242;246	G;G;A	228;225;228	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2874	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1436	198.7	0	.	p	.	0	F135L	NONSYN	403	405	TTT	644	646	CTT	215;216;213	C;T;T	206;206;203	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2874	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1436	198.7	0	.	p	.	0	R143G	NONSYN	427	429	AGA	668	670	GGA	202;205;203	G;G;A	190;191;189	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2874	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1436	198.7	0	.	p	.	0	D171G	NONSYN	511	513	GAT	752	754	GGT	208;208;212	G;G;T	192;194;193	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2874	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1436	198.7	0	.	p	.	0	G189S	NONSYN	565	567	GGC	806	808	AGC	237;237;233	A;G;C,T	216;213;209,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2874	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1436	198.7	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	872	872	T	217	T	198	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2874	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1436	198.7	1	SNP	p	G120K	0	.	.	358	360	GGT	599	601	GGT	241;239;235	G;G,A;T	219;215,2;203	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2874	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1436	198.7	1	SNP	p	A121N	0	.	.	361	363	GCC	602	604	GCC	235;233;231	G;C;C	213;213;210	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2874	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1436	198.7	1	SNP	p	A121D	0	.	.	361	363	GCC	602	604	GCC	235;233;231	G;C;C	213;213;210	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11244	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4712	237.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1941	1943	AAT	265;263;260	A;A,T;T	254;249,1;247	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1168	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1018	114.1	1	SNP	p	V57M	1	.	.	169	171	ATG	489	491	ATG	232;233;233	A;T;G	218;219;220	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
